PCM Trials acquires EmVenio to boost decentralised clinical trials
The acquisition will enable PCM to enhance recruitment and retention of diverse populations in decentralised clinical trials (DCTs).
PCM Trials WP 2
Labcorp partners with Hawthorne for decentralised clinical trials
Diversity and ePROs: Still siloed concepts in the era of DCTs?
DCT Tracker: Are sponsors getting better at conducting DCTs?
Telemedicine is yet to overcome diversity challenges in dermatology clinical trials
FDA’s DCT draft guidance: A hit or miss?
Medable and MRCT launch DCT review toolkit
Valneva publishes chikungunya vaccine data ahead of FDA review
